GLP-1 Drugs Are About to Destroy Medicare Costs
From The Retirement Nerds. Medicare is positioning to cover GLP-1 drugs for weight loss through two programs. Starting July 1, 2026 the Bridge program will provide access to GLP-1 weight-loss drugs — including Foundayo, Wegovy, and Zepbound — for eligible beneficiaries at $50/month. But there are important details the headlines aren’t telling you about the…







































